Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
VYCOR MEDICAL INC (VYCO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 8.2% | 8.5% | 13.6% | 8.5% | 10.6% | 11.6% | 10.6% | 8.0% |
| Gross profit | 91.8% | 91.5% | 86.4% | 91.5% | 89.4% | 88.4% | 89.4% | 92.0% |
| Selling, general and administrative | 67.2% | 76.8% | 110.1% | 109.7% | 101.5% | | 110.1% | 82.8% |
| Research and development | 1.6% | 1.5% | | | | 2.4% | 0.5% | 0.8% |
| General and administrative | | | | | | 139.8% | | |
| EBITDA | 23.1% | 13.5% | -23.4% | -18.1% | -11.9% | -53.5% | -21.1% | 8.5% |
| Depreciation | 3.1% | 4.3% | 5.0% | 4.6% | 5.0% | 5.6% | 4.6% | 3.1% |
| EBITA | 20.0% | 9.2% | -28.4% | -22.7% | -16.9% | -59.1% | -25.7% | 5.4% |
| Amortization of intangibles | | | | | | 0.9% | 0.9% | 0.6% |
| EBIT | 20.0% | 9.2% | -28.4% | -22.7% | -16.9% | -60.0% | -26.6% | 4.8% |
| Pre-tax income | 14.7% | 2.1% | -36.2% | -29.8% | -23.5% | -68.0% | 2.3% | 0.2% |
| Income taxes | 0.5% | 0.2% | 0.8% | 0.4% | 0.2% | 0.3% | 1.2% | 2.1% |
| Net income | 14.2% | -43.0% | -89.4% | -30.2% | -75.4% | -68.3% | -47.7% | -1.9% |
|